San Francisco And Freising

SAN FRANCISCO and FREISING, Germany, January 10, 2011 - Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today.